| Primary |
| Drug Use For Unknown Indication |
41.0% |
| Osteoporosis |
28.8% |
| Product Used For Unknown Indication |
5.8% |
| Osteoporosis Postmenopausal |
5.2% |
| Breast Cancer |
4.8% |
| Osteopenia |
3.0% |
| Hypertension |
2.9% |
| Pain |
1.6% |
| Rheumatoid Arthritis |
1.2% |
| Breast Cancer Metastatic |
1.1% |
| Hypothyroidism |
0.6% |
| Osteoarthritis |
0.6% |
| Osteoporosis Prophylaxis |
0.6% |
| Multiple Myeloma |
0.5% |
| Bone Disorder |
0.5% |
| Arthritis |
0.4% |
| Depression |
0.4% |
| Back Pain |
0.3% |
| Bone Density Decreased |
0.3% |
| Metastasis |
0.3% |
|
| Death |
67.8% |
| Osteonecrosis |
3.6% |
| Pneumonia |
3.0% |
| Myocardial Infarction |
2.7% |
| Femur Fracture |
2.5% |
| Vomiting |
2.3% |
| Renal Failure |
1.6% |
| Hip Fracture |
1.5% |
| Thrombosis |
1.5% |
| Gastrointestinal Haemorrhage |
1.3% |
| Neoplasm Malignant |
1.3% |
| Spinal Fracture |
1.3% |
| Tooth Extraction |
1.3% |
| Cerebrovascular Accident |
1.2% |
| Pain |
1.2% |
| Wrist Fracture |
1.2% |
| Breast Cancer |
1.1% |
| Respiratory Failure |
1.1% |
| Cardiac Failure |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
|
| Secondary |
| Osteoporosis |
28.1% |
| Product Used For Unknown Indication |
22.1% |
| Breast Cancer |
8.8% |
| Drug Use For Unknown Indication |
7.1% |
| Osteopenia |
5.3% |
| Metastases To Bone |
4.9% |
| Rheumatoid Arthritis |
3.8% |
| Breast Cancer Metastatic |
3.1% |
| Multiple Myeloma |
3.1% |
| Osteoporosis Postmenopausal |
2.7% |
| Premedication |
1.8% |
| Chemotherapy |
1.5% |
| Hypertension |
1.3% |
| Hypercalcaemia Of Malignancy |
1.1% |
| Hypothyroidism |
1.1% |
| Anxiety |
0.9% |
| Coronary Artery Disease |
0.9% |
| Pain |
0.9% |
| Pancytopenia |
0.9% |
| Constipation |
0.7% |
|
| Osteonecrosis |
11.6% |
| Vomiting |
9.5% |
| Tooth Extraction |
8.4% |
| Femur Fracture |
7.4% |
| Osteonecrosis Of Jaw |
6.3% |
| Pain |
6.3% |
| Hip Fracture |
5.3% |
| Colitis Ulcerative |
4.2% |
| Pelvic Fracture |
4.2% |
| Rash |
4.2% |
| Renal Failure |
4.2% |
| Vision Blurred |
4.2% |
| Weight Decreased |
4.2% |
| Impaired Healing |
3.2% |
| Pain In Extremity |
3.2% |
| Paraesthesia |
3.2% |
| Product Quality Issue |
3.2% |
| Sudden Death |
3.2% |
| Bone Metabolism Disorder |
2.1% |
| Escherichia Infection |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.5% |
| Rheumatoid Arthritis |
18.6% |
| Drug Use For Unknown Indication |
15.8% |
| Osteoporosis |
8.7% |
| Hypertension |
5.9% |
| Pain |
5.5% |
| Hypercholesterolaemia |
5.4% |
| Her-2 Positive Breast Cancer |
2.9% |
| Depression |
2.6% |
| Atrial Fibrillation |
2.1% |
| Breast Cancer |
2.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.7% |
| Prophylaxis |
1.6% |
| Osteoarthritis |
1.4% |
| Metastases To Bone |
1.2% |
| Multiple Myeloma |
1.1% |
| Arthralgia |
1.0% |
| Colorectal Cancer Metastatic |
1.0% |
| Diabetes Mellitus |
1.0% |
| Renal Cell Carcinoma |
1.0% |
|
| Pyrexia |
8.6% |
| Urinary Retention |
8.6% |
| Tendonitis |
7.4% |
| Cerebral Infarction |
6.2% |
| Heart Rate Increased |
4.9% |
| Hyperhidrosis |
4.9% |
| Mouth Ulceration |
4.9% |
| Neutropenic Sepsis |
4.9% |
| Pain |
4.9% |
| Pancreatitis Acute |
4.9% |
| Pleural Effusion |
4.9% |
| Weight Decreased |
4.9% |
| Anal Fistula |
3.7% |
| Death |
3.7% |
| Femoral Neck Fracture |
3.7% |
| Granuloma Annulare |
3.7% |
| Optic Neuritis |
3.7% |
| Paraesthesia |
3.7% |
| Pneumonia |
3.7% |
| Renal Cell Carcinoma |
3.7% |
|
| Interacting |
| Breast Cancer |
60.0% |
| Metastasis |
25.7% |
| Breast Cancer Metastatic |
5.7% |
| Osteoporosis |
5.7% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Postmenopause |
1.4% |
|
| Osteonecrosis |
66.7% |
| Osteoporosis |
11.1% |
| Surgery |
11.1% |
| Weight Decreased |
11.1% |
|
